Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation<blockquote>赛诺菲和葛兰素史克宣布其 COVID-19 候选疫苗的积极初步加强数据,并根据独立监督委员会的建议继续进行 3 期试验</blockquote>
Keppel raises SPH bid to S$2.351 a share, cash component up by 20 cents; says price is final<blockquote>吉宝将 SPH 出价提高至每股 2.351 新元,现金部分提高 20 美分;说价格是最终的</blockquote>